Suchergebnisse - "Shimoji, Masaki"

PubPharm (58)

1

A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation

enthalten in: Surgical case reports | 2024

von Shimizu, R. | Suda, K. | Takemoto, T. | +6

2

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Hamada, A. | Suda, K. | Nishino, M. | +14

CommentIn: J Thorac Oncol. 2024 Jan;19(1):10-12. - PMID 38185508

3

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

enthalten in: JTO clinical and research reports | 2023

von Koga, T. | Soh, J. | Hamada, A. | +12

4

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

enthalten in: Journal of hematology & oncology | 2022

von Fujino, T. | Suda, K. | Koga, T. | +7

5

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

enthalten in: Journal of hematology & oncology | 2022

von Fujino, T. | Suda, K. | Koga, T. | +7

6

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

enthalten in: Journal of hematology & oncology | 2022

von Fujino, T. | Suda, K. | Koga, T. | +7

7

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC

enthalten in: JTO clinical and research reports | 2022

von Hamada, A. | Suda, K. | Fujino, T. | +12

8

Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer

enthalten in: Clinical lung cancer | 2022

von Suda, K. | Ohara, S. | Fujino, T. | +6

9

In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Hamada, A. | Suda, K. | Koga, T. | +9

10

The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgery

enthalten in: Surgery today | 2021

von Takemoto, T. | Soh, J. | Ohara, S. | +9

1
2
3
4
5
6
Nächster »
[6]